To assess the diagnostic value of lung scintigraphy and helical computed tomography (hCT) in patients with suspected pulmonary embolism (PE), all English-language articles that described lung scintigraphy and hCT in patients with suspected PE were retrieved. Articles were assessed for strength of methodology, based on nine a priori-defined criteria. Parameters of diagnostic accuracy and results of management studies were calculated and evaluated. Lung scintigraphy is diagnostic in approximately 50% of patients with suspected PE. A normal perfusion scan has a chance of recurrent PE in two of 693 patients (0.3%; 95% CI: 0.2-0.4%; fatal in 0.15%). A highprobability lung scan is corrected with angiographically proven PE in 308 of 350 patients (88%; 95% CI: 84-91%). Pulmonary embolism was proven in 385 of 1529 patients (25%; 95% CI: 24-28%) with a nondiagnostic lung scan. Helical CT studies were compared with angiography and lung scintigraphy in 1171 patients, with a prevalence of PE of 39%. The sensitivity and specificity of hCT was 283/320 (88%; 95% CI: 83-91%) and 374/408 (92%; 95% CI:89-94%), respectively. Only one prospective management study using hCT was available. In patients in whom anticoagulants were withheld based on a normal hCT study, recurrent thromboembolic events occurred in six of 109 patients (5.5%; 95% CI: 2-12%), with one fatality (1%; 95% CI: 0.02-4.3%). Lung scintigraphy is evaluated extensively and yields a diagnostic result in 50% of patients.
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Helical CT has similar positive predictive value to a highprobability lung scan. However, the exact role of hCT in the management of patients with suspected PE needs to be determiined in prospective studies. Key Words: Helical computed tomography&mdash;Lung scintigraphy&mdash;Putmonary embolism.
In spite of improved prophylaxis, pulmonary embolism (PE) remains one of the main causes of morbidity and mortality in the western world. Approximately two to three patients per 1000 inhabitants are yearly suspected of having PE (1) (2) (3) . Adequate diagnostic tests are required to distinguish patients who have PE from those that have other, often nonserious, illnesses. The reason for this diagnostic process are two-fold: the natural history ofPE (i.e., missing the diagnosis) is thought to result in fatal and nanf~t~ recurrent PE in 30%. of patients in category, respectively (4) . On the other hand, treatment with anticoagulants will result in bleeding complications, which are fatal and major in 1% and 7% per treatment year, respectively (5, 6) . Thus, both underdiagnosis and overtreatment should be avoided.
The diagnosis traditionally depended on clinical assessment. However, as demonstrated by studies that ap-plied pulmonary angiography, the prevalence cif pulmcrnary embolism in patients who are clinically suspected is only 30% (7-i l ~, Furthermore, many patients are not diagnosed until they are seen by a pathologist (1) . Hence, the threshold for suspicion is generally low, in order to miss as few patients as possible.
Although several noninvasive, diagnostic tests have advocated over recent years, this overview is limited to the assessment of the evidence for the use of two diagnostic tests: lung scintigraphy (both perfusion and ventilation) and the helical computed tomography (hCT).~1
TE LS AND METHODS
Articles were identified through the Medline database and Current Contents, which described studies using lung scintigraphy and hCT in patients with suspected pulmonary embolism. The search was limited to articles published in the English language, with a final inclusion date of June i ; 1999. Abstracts were not included in the analysis.
Articles were reviewed and predefined criteria were set. Two types of publications were accepted in this analysis: diagnostic accuracy studies and management studies with follow-up. Several criteria, which were defined a priori, needed to be met for inclusion into this ' analysis. These were: 1) prospective study in consecutive patients; 2) adequate description of studied patients; 3) sensitivity and specificity evaluation versus pulmonary angiography; 4) blinded comparison with pulmonary angiography ; 5) description of imaging techniques; 6) management studies with an adequate description of how follow-up was performed; 7) minimum follow-up of 3 'months; 8) description of diagnosis in patients with recurrent symptoms; and 9) original (nonduplicated) articles only.
Using these criteria, the two diagnostic imaging modalities were assessed for diagnostic accuracy ~i.e.; sensitivity and specificity) and influence of different observer (inter-observer variability). Finally, the evidence of clinical utility in clinical practice, as demonstrated by management studies, was evaluated. Statistical analysis was performed by means of a primary assessment of sensitivity, specificity when comprison was made with pulmonary angiography and recurrent thromboembolic events in management studies.
Recurrent thromboembolic events were further subdivided into fatal PE and nonfatal PE. Overall 95% confidence intervals were calculated.
RESULTS

Lung scintigraphy
Tee~tttqccL ung scintigraphy uses radioactive tracers to assess basic lung physiology. Perfusion lung scintigraphy makes use of 99'Technetium-label led macro-aggregates of albumin (12) . These particles are injected intravenously with the patient supine and taking a deep breath, which guarantees optimal dispersion into the pulmonary vascular bed, where they become trapped. Only a fraction of the capillaries (in the order of 1 %) are temporarily obstructed (13) . The lungs are imaged in six standard projections using a camera. Perfusion defects are identified as areas of hypoor nonperfusion. Ventilation scintigraphy is performed by introducing a ' radiotracer into the airways. This radiotracer may be a gas, such as8&dquo;-Krypton or 133 Xenon, or an aerosol that is labelled with ~~'T~~hnetit~m, such as diethylene triamine penta-acetic acid (DTPA) or carbon (Technegas). These agents have different characteristics (14) . The inefl ~ ~ ~Krypton gas has the advantage of a short half-life and may be used simultaneously with the perfusion scan, but its costs and availability are limiting factors. 99mTechnetium-labelled aerosols are easier to obtain, but have the disadvantage of central deposition, which is especially marked in patients with pulmonary diseases, resulting in diminished visualisation of the pe~i~h~ral ' airways. Another inert gas, 133 Xenon, is commonly used but has the disadvantage that ventilation images have to ' ' be obtained before perfusion scintigraphy. The lungs are imaged in the same six projections as the perfusion lung ; ; scan. Complications of lung scintigraphy are rare and ; mainly caused by allergic reactions related to the admin-/ istration of the albumin particles.
! Classification
The classification of lung scan results have been a i matter of debate for many years. Several attempts were i made (11, 15, 16) , and one study compared three classifi-i cations in a group of 96 patients ( ~ ~7~. This study showed ! that the Prospective Investigation of Pulmonary Embo-I I lism Diagnosis (PIOPED) criteria best predicted the I ' presence of PE, but was worst in excluding the disease as ! compared with the other two classifications. Subse-! / quently, the PIOPED criteria were revised in an attempt / to improve the exclusion capability, but this led to a false-negative rate of up to 16% in patients with a tr~~us ~ I I probability lung scan 18).
A more clinically useful classification is to divide the lung scan results into three categories: 1) a normal per-! i fusion scan, indicating the absence of pulmonary embo-! lism; 2) a high-probability lung scan, defined as one or ! more defects of at least segmental size with normal matching ventilation, which indicates the presence of I emboli; and 3) the remaining lung scan results, referred I to as nondiagnostic scan, which would require further diagnostic tests (19) . In a recent, direct comparison in 570 patients using this simple classification versus the revised PIOPED criteria, it was shown that the more complicated PIOPED criteria offer no advantage (20) .
Using a variety of classifications, there is about 10 to 20% observer disagreement for lung scan reporting I (21, 22) . The use of an anatomical lung segment chart is ; useful, because it improves the intra-and interobserver I variability of reporting (23) . ' / Normal lung scan [ The clinical validity of a normal perfusion lung scan has been documented in three well-designed studies ~~'I-26). In a total of 693 patients with a normal perfusion lung scan in whom anticoagulants were withheld, two patients (0.3%; 959h CI: 0.2-0.4%) had a thromboem-1 bolic event during a follow-up period of at least 3 / months, one of them fatal. Hence, it is deemed safe tao withhold anticoagulants in patients with a normal perfu-/ sion lung scan. An exception is the patient with a high ' clinical suspicion of pulmonary embolism and a normal, perfusion lung scan (27) .
I j l~gh-~~~-r~ba~ility ~r~~~ s~~ñ
A total of nine studies were identified, which compared a high-probability lung scan (as defitied at least one segmental mismatch) with pulmonary angiography (8) (9) (10) (11) 16, (28) (29) (30) (31) . The positive predictive in 350 patients was 88% (95% Cl: 84.-~ l ~o~. In the majority of patients, this is sufficient to warrant treatment with anticoagulants. However, one has to remain aware that other disorders than pulmonary embolism can cause perfusion-ventilation mismatch (32) . Therefore, in patients who have an increased bleeding risk, it may be necessary to perform pulmonary angiography after all.
Nondiagnostic lung scan
Using a three-result classification, a total of 12 studies, were identified that compared a nondiagnostic lung scan with pulmonary angiography (8) (9) (10) (11) 16, (33) (34) (35) (36) . Briefly, helical computed tomography (hCT) is using radiograms similar to conventional CT, but hCT moves the patient through the scanner during imaging. This results in a helical motion of the radiograph tube around the patient. During scanning, intravenous contrast material is injected with an aim to opacify the pulmonary arterial tree. The obtained (volumetric) data can be reconstructed in transverse and multiplanar fashion.
C~M~ca~o~ ' Similar to pulmonary angiography, pulmonary emboli seen during hCT are defined as intraluminal filling defects or complete nonfilling of a pulmonary arterial branch (36) . Although many different patterns of additional signs have been described, these have not been shown helpful in identifying patients with or without PE (37, 38) .
The interobserver variations has been investigated in several studies (~9~41 ~. The observer agreement, as shown by K statistic, was high in all studies. How-' ever, more disagreement consisted in patients with previous nondiagnostic lung scans and in smaller pulmonary emboli, raising the issue of sensitivity in subsegmental PE (39, 41) . The sensitivity in this subgroup dropped from approximately 90 to 67% (39) . This is an important issue, as up to 30% of patients with suspected PE will have emboli limited to the subsegmental arteries ~42-~4).
Diagnostic accuracy studies
Initial studies assessed the accuracy of helical CT in patients with (suspected) massive or central PE. The first study by Remy-Jardin in a selected series of 18 patients with central PE showed a sensitivity and specificity of 100% (36) . Subsequently, a total of 12 studies assessed sensitivity and specificity using lung scintigraphy (45) , pulmonary angiography ~~:6-~-5 ~') or a combination of lung scintigraphy and pulmonary angiography (39, 40, (52) (53) (54) as reference method. These studies are summarized in Table 1 . The overall sensitivity and specificity are 88% (95% Cl: 83-9!%) and 92% (95% Cl: 8~-~~~lo), respectively.
The high prevalence in some of these studies indicates that they were more focused on central PE, which may influence the overall figures. Several studies evaluated * Angiography in 26 patients; follow-up in 28 patients. tCT only in 77 patients with non-normal perfusion scintigraphy; angiography in 42 patients with non-diagnostic lung scan and in 3 patients with high probability lung scan and normal spiral CT. tCT in all 149 patients: PE excluded by perfusion scan (40) or angiogram (41) ; PE proven by high probability scan (53) or angiogram (15) . the influence of embolus size on sensitivity and specificity (39, 48, 49) . This revealed that the sensitivity is markedly lower for subsegmental PE, and appears to be in the range of 50 to 65% (39, 48, 49) .
Another important issue is the number of technically inadequate helical CT investigations. This ranged between 3 and 6% (40, 51, 52, 54) . More recent studies have shown that these figures can be improved further. Using smaller collimation of 2 mm (55) and multiplanar reconstruction algorithms (56) can further improve visualization of segmental and even subsegmental arteries. Thus, the current accuracy figures may be further improved on with the implementation of better imaging protocols.
Management studies
Only a few studies have evaluated the outcome of patients with suspected pulmonary embolism in which helic~.t CT played a role in management. One prospective management study in 164 patients with nondiagnostic lung scan findings and normal duplex ultrasonography of the leg veins made use of hCT (57) . This study showed PE in 39 (24%) patients, who were promptly treated with anticoagulants therapy. Angiography was performed in 15 patients with normal hCT findings caused by high clitiical suspicion, and this showed PE in one patient. Three months follow-up was obtained in the 109 patients with a norman hCT study, who did not receive anticoagulant therapy based on a normal hCT study. One patient died because of recurrent PE, two developed nonfatal recurrent PE, and three were diagnosed with unexplained deep-vein thrombosis (one further patient suffered local thrombosis following angiography). Thus, recurrent thromboembolic events occurred in 5.5% of patients (95% Cl: 2-=12~~~, with a 1% fatality rate (9~~1~ CI: 0.02-4.3%). These results compare unfavorably with those of management studies, which used lung scintigraphy and pulmonary angiography (58) (59) (60) .
A second study consisted of a retrospective review of 126 patients who had hCT during the course of their management (~ I ~. Six months follow-up was complete in 78 patients with a n~~n~.l hCT who remained untreated. None of these patients died of recurrent PE, and autopsy revealed small PE in only one patient. For comparison, a dp c~~ ~f~ pa~i~nts ~ith nc~rcna~. p~ i~n ~~inti p~ygroup of 46 patients with normal perfusion scintigraphy showed no recurrent PE, but in a group of 132 patient with low probability two fatal and one nonfatal embolic events were recorded.
Finally, another retrospective review of 143 patients who underwent hCT for suspected PE was carried out (62) . Six months follow-up was aimed for in 113 patients with normal hCT patients who remained untreated. During follow-up, contact with 13 patients was lost and 19 died (none reportedly from PE), whereas no recurrent PE was documented in the remaining 81 patients. DISCUSSION Lung scintigraphy has been well evaluated. For patient management, two results are sufficient: a normal perfuscion scan adequately excludes PE, whereas a high probability scan result is sufficient proof to warrant anticoagulant therapy in most patients. Nevertheless, one needs to be aware that PE may be absent in as many as 12% of patients with a high-probability lung scan result. Helical CT is a newer technique that has not been fully evaluated yet. The results are promising, and there is ; some evidence that hCT can replace (in part) lung scin-/ tigraphy. If thrombus is evident at hCT, this is sufficient to warrant anticoagulant therapy. In patients with susi pected PE and normal hCT findings, however, further diagnostic work-up is required. Some have suggested i that alternative findings during hCT, such as at~l~ctasis, ; i tumor, or pleural effusion in the absence of PE may adequately exclude PE and that patients could remain j without anticoagulant therapy. However, a recent 'study suggested that alternative findings are equally present in those with and without PE (38) . Furthermore, nor prospective management studies exist to support this I notion. Thus, at present, it should be regarded unsafe to I withhold anticoagulant therapy in patients with normal hCT findings. !
